Several copycat versions of the drug have already been approved, including from Zydus Cadila and Lupin Labs ... stop Pfizer’s generic medicines unit Hospira launching a copycat version of ...

Zydus Lifesciences share price today, March 19: The share price of Zydus Lifesciences has risen by 1.8% in the past five trading sessions. (Image: Freepik) Zydus Lifesciences rose 3% to an intra ...

The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

The recent approval enables Zydus Lifesciences to produce and sell Apalutamide Tablets, 60 mg (a generic equivalent of Erleada) in the United States. Apalutamide is an androgen receptor inhibitor ...

Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...

Zydus Lifesciences share price extended the gains on third consecutive session on March 19, rising more than 1 percent after company received final approval from USFDA for Apalutamide Tablets, 60 ...

Zydus Lifesciences Ltd share price was down by -1.77% from the previous closing price of ₹923.70. Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun ...

The Board has extended Rajivnayan Rahulkumar Bajaj's tenure as Managing Director and Chief Executive Officer for another five years, starting April 1. Additionally, Abhinav Bindra has been ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...